Publications of F. Holsboer

Jastorff, A. M.; Haegler, K.; Maccarrone, G.; Holsboer, F.; Weber, F.; Ziemssen, T.; Turck, C. W.: Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Proteomics Clinical Applications 3 (11), pp. 1273 - 1287 (2009)

Yehuda, R.; Cai, G. Q.; Golier, J. A.; Sarapas, C.; Galea, S.; Ising, M.; Rein, T.; Schmeidler, J.; Müller-Myhsok, B.; Holsboer, F. et al.; Buxbaum, J. D.: Gene Expression Patterns Associated with Posttraumatic Stress Disorder Following Exposure to the World Trade Center Attacks. Biological Psychiatry 66 (7), pp. 708 - 711 (2009)

Brückl, T.; Lieb, R.; Pfister, H.; Wittchen, H. U.; Holsboer, F.; Ising, M.; Zimmermann, P.: Polymorphisms in the serotonin receptor 2A gene (HTR2A), parenting styles and the risk of depression in young adulthood: results from a family study. Pharmacopsychiatry 42 (5), p. 213 - 213 (2009)

Ditzen, C.; Varadarajulu, J.; Czibere, L.; Gonik, M.; Bunck, M.; Teplytska, L.; Müller-Myhsok, B.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways. Pharmacopsychiatry 42 (5), pp. 215 - 216 (2009)

Goya-Maldonado, R.; Spoormaker, V. I.; Chechko, N.; Höhn, D.; Andrade, K.; Kluge, M.; Steiger, A.; Holsboer, F.; Czisch, M.; Sämann, P. G.: Subregional amygdala functional connectivity: normative maps and influence of oral citalopram in healthy volunteers. Pharmacopsychiatry 42 (5), p. 219 - 219 (2009)

Heck, A.; Szesny, N.; Holsboer, F.; Reppermund, S.; Ising, M.: Polymorphisms of the dopamine beta-hydroxylase (DBH) gene show associations with cognitive flexibility in mentally healthy adults. Pharmacopsychiatry 42 (5), p. 221 - 221 (2009)

Hennings, J. M.; Owashi, T.; Binder, E. B.; Horstmann, S.; Menke, A.; Kloiber, S.; Messer, T.; Pollmächer, T.; Nickel, T.; Sonntag, A. et al.; Uhr, M.; Ising, M.; Holsboer, F.; Lucae, S.: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - Findings from the Munich Antidepressant Response Signature project. Pharmacopsychiatry 42 (5), p. 222 - 222 (2009)

Horstmann, S.; Menke, A.; Hennings, J. M.; Lucae, S.; Straub, V.; Spieler, D.; Wollweber, B.; Holsboer, F.; Binder, E. B.: Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study. Pharmacopsychiatry 42 (5), p. 223 - 223 (2009)

Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.; Menke, A.; Bondy, B.; Rupprecht, R.; Domschke, K.; Baune, B. T.; Arolt, V.; Rush, A. J.; Holsboer, F.; Müller-Myhsok, B.: A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 66 (9), pp. 966 - 975 (2009)

Ising, M.; Lucae, S.; Binder, E. B.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M. A.; Hennings, J. M.; Horstmann, S.; Kloiber, S. et al.; Menke, A.; Bondy, B.; Rupprecht, R.; Domschke, K.; Baune, B. T.; Arolt, V.; Rush, A. J.; Holsboer, F.; Müller-Myhsok, B.: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 42 (5), p. 224 - 224 (2009)

Kirmeier, T.; Ganal, V.; Ranganath, G.; Flachskamm, C.; Maccarrone, G.; Turck, C. W.; Hausch, F.; Holsboer, F.; Rein, T.: Modified antidepressants as innovative tools for identifying novel drug targets. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)

Kloiber, S.; Kohli, M. A.; Brückl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Lucae, S.: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 42 (5), p. 226 - 226 (2009)

Knapp, R. T.; Konzany, C.; Weidinger, E.; Hafner, K.; Holsboer, F.; Hausch, F.; Rein, T.: Steroid receptor folding and signaling is regulated by the Hsp70 cochaperones BAG-1 M and HspBP1. Pharmacopsychiatry 42 (5), p. 227 - 227 (2009)

Lang-Rollin, I.; Holsboer, F.; Rein, T.: Can GR function be predicted from the relative cellular amounts of accessory proteins of the GR folding platform? Pharmacopsychiatry 42 (5), pp. 228 - 229 (2009)

Lucae, S.; Kohli, M. A.; Schmidt, M. V.; Sämann, P. G.; Demirkan, A.; Hek, K.; Salyakina, D.; Ripke, S.; Roeske, D.; van Duijn, C. M. et al.; Uhr, M.; Bettecken, V.; Holsboer, F.; Müller-Myhsok, B.; Binder, E. B.: The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 42 (5), p. 230 - 230 (2009)

Menke, A.; Roeske, D.; Domschke, K.; Holsboer, F.; Binder, E. B.: Genome-wide association study of antidepressant induced treatment emergent suicidal ideation (TESI). Pharmacopsychiatry 42 (5), p. 230 - 230 (2009)

Rosenhagen, M. C.; Höhn, D.; Schuessler, P.; Menke, A.; Holsboer, F.; Uhr, M.: Polymorphisms in the drug transporter gene ABCB1 in treatment resistant depression: clinical practice. Pharmacopsychiatry 42 (5), p. 238 - 238 (2009)

Sämann, P. G.; Höhn, D.; Holsboer, F.; Czisch, M.: Proton-MR-spectroscopy (1 H-MRS) of the left hippocampus and anterior cingulate cortex in recurrent unipolar depression: results from 176 subjects. Pharmacopsychiatry 42 (5), p. 238 - 238 (2009)

Schmidt, U.; Gall-Kleebach, D.; Pfister, H.; Czesny, N.; Spoormaker, V. I.; Rein, T.; Uhr, M.; Bettecken, T.; Holsboer, F.; Ising, M.: The Munich PTSD Biomarker Study (MPBS). Pharmacopsychiatry 42 (5), p. 240 - 240 (2009)

Schmidt, U.; Touma, C.; Gassen, N.; Christian, L.; Asmus, S.; Cox, M. B.; Hausch, F.; Schmidt, M. V.; Holsboer, F.; Rein, T.: Deletion of FKBP5 alters stress-related parameters in mice. Pharmacopsychiatry 42 (5), p. 240 - 240 (2009)